# Immucell Corp: Form 8-K, filed Nov 4, 2025

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2025-11-04
- Accepted by EDGAR: Nov 4, 2025, 21:08 ET
- Period: 2025-10-29
- Accession: 0001437749-25-033017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/iccc20251103_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/iccc20251103_8k.htm

Filed Nov 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-033017. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.
